
|Videos|June 8, 2018
Impact and Implications of Lung Cancer Screening
Author(s)James Mulshine, MD
In this video at ASCO 2018, James Mulshine, MD, discusses CMS coverage of low-dose CT lung cancer screening for selected Medicare beneficiaries, and clinical implications of early detection.
Advertisement
In this video at ASCO 2018, James Mulshine, MD, discusses CMS coverage of low-dose CT lung cancer screening for selected Medicare beneficiaries, and clinical implications of early detection.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer
2
FDA Approves Subcutaneous Isatuximab in Multiple Myeloma
3
HARMONi-6: Evaluating the Safety and Generalizability of Ivonescimab in NSCLC
4
EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process
5















































































